GlaxoSmithKline Plc (GSK)

41.03
0.01 0.02
NYSE : Health Technology
Prev Close 41.04
Open 41.29
Day Low/High 40.79 / 41.29
52 Wk Low/High 34.52 / 44.45
Volume 2.34M
Avg Volume 2.73M
Exchange NYSE
Shares Outstanding 2.48B
Market Cap 101.98B
EPS 0.80
P/E Ratio 23.72
Div & Yield 2.18 (5.25%)

Latest News

GSK Submits Regulatory Application In Japan For Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI For Patients With COPD

GSK Submits Regulatory Application In Japan For Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI For Patients With COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for once-daily fluticasone furoate/umeclidinium/vilanterol...

Trump Administration Ups Dose Of Shame As TV Drug Ad Policy Idea Moves Forward

Trump Administration Ups Dose Of Shame As TV Drug Ad Policy Idea Moves Forward

President Trump's appetite for TV and ratings is legendary and now the administration wants to require drug company TV ads to include the list price of prescription drugs.

20 Top Stocks From Around the World With an Average 25% Upside Potential

20 Top Stocks From Around the World With an Average 25% Upside Potential

In this market, picking the right stocks is paramount. Here is a tidy list of top ideas from the strategy team at HSBC.

What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week

What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week

The drugmakers and health insurer are preparing to unveil first-quarter numbers.

Walgreens, Arena Pharma, Dominion Energy: 'Mad Money' Lightning Round

Walgreens, Arena Pharma, Dominion Energy: 'Mad Money' Lightning Round

Jim Cramer focuses on Walgreens Boots Alliance, Arena Pharmaceutical, Dominion Energy, Tower Semiconductor, Idexx, LexinFintech Holdings and more.

FANG, Tariffs, Trade: Cramer's 'Mad Money' Recap (Thursday 4/26/18)

FANG, Tariffs, Trade: Cramer's 'Mad Money' Recap (Thursday 4/26/18)

It's not all about the bond market, says Jim Cramer. The central issues here are trade, tariffs and most important, the stocks themselves, like Facebook and Amazon.

Innoviva Is Attractive Play in Biotech

Innoviva Is Attractive Play in Biotech

Strong balance sheet and royalties are big positives for Innoviva.

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Once-Daily Trelegy Ellipta Gains Expanded Indication In The US For The Treatment Of Patients With COPD

Once-Daily Trelegy Ellipta Gains Expanded Indication In The US For The Treatment Of Patients With COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol 'FF/UMEC/VI'), which...

Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business

Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business

Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.

Mylan's Stock Gets Bump After Investor Day

Mylan's Stock Gets Bump After Investor Day

Following Wednesday's event, Leerink analyst Ami Fadia said she is 'incrementally more positive' on the drugmaker's pipeline and diversified business model and moved her rating to outperform.

Novartis Agrees to Buy AveXis in $8.7 Billion Deal

Novartis Agrees to Buy AveXis in $8.7 Billion Deal

The acquisition is a big move for Novartis CEO Vas Narasimhan, who took the helm in February.

Blackberry, SkyWest, Apache: 'Mad Money' Lightning Round

Blackberry, SkyWest, Apache: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Blackberry, SkyWest, Apache, Philip Morris International, PetMed Express, Iron Mountain, Novartis.

Behind the Selloff: Cramer's 'Mad Money' Recap (Friday 4/6/18)

Behind the Selloff: Cramer's 'Mad Money' Recap (Friday 4/6/18)

This market is deceptive and you need to recognize your sense of timing is not infallible. So, adjust your scales and get ready for next week, says Jim Cramer.

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

M&A activity kicks into high gear going into the final days of the first quarter. If the broader stock market doesn't pop on this news, it would be a red flag.

4 Strong Buy Biotech Stocks Poised to Explode

4 Strong Buy Biotech Stocks Poised to Explode

Here comes the growth. These four strong buy biotech stocks are potentially on the cusp of very big growth.

The Dow Plunges Into the Close of Trading on Tuesday

The Dow Plunges Into the Close of Trading on Tuesday

Cooling tensions with China aren't enough to save investors on Tuesday.

Novartis to Exit its Consumer Business and 4 Other Stories You Must Know Tuesday

Novartis to Exit its Consumer Business and 4 Other Stories You Must Know Tuesday

With Wall Street responding to one of the strongest rallies in years, here's what you need to know premarket Tuesday.

Facebook, Novartis, GSK, Uber and Deutsche Bank - 5 Things You Must Know

Facebook, Novartis, GSK, Uber and Deutsche Bank - 5 Things You Must Know

U.S. stock futures rise and global stocks extend their rally; Novartis to sell 36.5% stake in joint venture to partner GSK for $13 billion; Facebook's Mark Zuckerberg won't face U.K. lawmakers.

Global Stocks Ride Wall Street Wave as U.S.-China Trade Talks Tempt Bulls

Global Stocks Ride Wall Street Wave as U.S.-China Trade Talks Tempt Bulls

Wall Street's best day in nearly three years has global stocks on the move Tuesday, with U.S.-China trade talks and a wave of late quarter M&A boosting markets around the world.

Global Stocks Tumble as China Fires Back in Trump Trade War

Global Stocks Tumble as China Fires Back in Trump Trade War

Global stocks tumbled, with markets in Asia losing all of their year-to-date gains, as China declared it's "not afraid" of an escalating trade war with the United States following President Trump's decision to target $50 billion in China-made goods.

GlaxoSmithKline Looks Poised for an Upside Move

GlaxoSmithKline Looks Poised for an Upside Move

GSK is still below the declining 200-day moving average line but a rally of $2 will challenge the line.

GSK Announces Positive EU Approval For Labelling Update To Relvar Ellipta In Patients With Asthma

GSK Announces Positive EU Approval For Labelling Update To Relvar Ellipta In Patients With Asthma

GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has approved a label update for the use of once-daily Relvar Ellipta (fluticasone furoate/vilanterol, FF/VI),...

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

The Swiss pharmaceutical firm's U.S. generic pill business could attract as much as $1.6 billion, Reuters reported.

Big Pharma, Big Blimps and 3 Other Names That Look Good Short

GSK, EXPE, GT, UHAL and UBNT were all recently were downgraded by TheStreet's Quant Ratings service.

GSK Submits Landmark IMPACT Data To European Medicines Agency To Support Expanded Label For Trelegy Ellipta

GSK Submits Landmark IMPACT Data To European Medicines Agency To Support Expanded Label For Trelegy Ellipta

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the submission of the landmark IMPACT data to the European Medicines Agency as part of a type II variation to support an expanded label...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CG, FLO, GNW, IART, LITE, MX, PDVW, PFPT, STO, TTWO Downgrades: AINV, BCO, BZH, CRCM, GSIT, GSK, IESC, ISRL, MLAB, MTCH, NEU, NNN, PZN, SGA Initiations: TRVG Read on to get TheStreet Quant Ratings' detailed report:

GSK Announces CHMP Positive Opinion For Labelling Update To Relvar Ellipta In Patients With Asthma

GSK Announces CHMP Positive Opinion For Labelling Update To Relvar Ellipta In Patients With Asthma

GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion...

TheStreet Quant Rating: C (Hold)